Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Haematologica|March 26, 2016
Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndromeMichaela Nováková, Markéta Žaliová, Martina Suková, et al.
Blood Advances|July 23, 2021
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trialCharlotte M Niemeyer, Christian Flotho, Daniel B Lipka, et al.
Haematologica|January 2, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, et al.
Bone Marrow Transplantation|July 10, 2021
Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndromeRachel Bortnick, Marcin Wlodarski, Valerie de Haas, et al.
Nature Genetics|August 10, 2010
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Michelle W Kang, Danielle H Shin, et al.
Blood|December 25, 2015
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescentsMarcin W Wlodarski, Shinsuke Hirabayashi, Victor Pastor, et al.
Leukemia|June 20, 2020
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiencyEmilia J Kozyra, Victor B Pastor, Stylianos Lefkopoulos, et al.
Blood Cancer Journal|July 15, 2025
Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiencyLili Kotmayer, Emilia J Kozyra, Guolian Kang, et al.
Pageof 5